Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Ann Allergy Asthma Immunol ; 110(2): 92-5, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23352527

RESUMEN

BACKGROUND: Aspirin prevents coronary thrombosis and is used extensively in cardiovascular prophylaxis. However, patients with a prior history of an aspirin "reaction" are routinely denied this medication. OBJECTIVE: To characterize the clinical presentation of a cohort of patients with coronary artery disease (CAD) and aspirin reactions. METHODS: Between 2009 and 2012, using a retrospective computer analysis, information was collected on all patients within a county-wide health care system presenting with CAD and a prior history of aspirin reactions. RESULTS: Of 9,565 patients with CAD, a prior history of aspirin reactions was recorded in 142 patients. Of these 142 patients, 30 (21%) had histories compatible with cutaneous and/or respiratory reactions. The other patients described adverse effects to aspirin, mostly gastrointestinal intolerance and bleeding. Aspirin-induced anaphylaxis was recorded in patients but may have been misdiagnosed, describing instead respiratory hypersensitivity reactions. Of the 142 patients, only 34 (24%) were receiving daily cardiovascular prophylaxis with aspirin. Of 108 patients not receiving aspirin, 25 (17.6%) were prescribed clopidogrel. CONCLUSION: Histories of aspirin reactions in patients with CAD are uncommon, occurring in only 1.5% of our study population. The 21% of patients with histories compatible with aspirin hypersensitivities can be challenged and, if the results are positive, successfully desensitized. Moreover, almost all patients with gastric intolerance to aspirin can be treated with aspirin and a proton pump inhibitor. However, both approaches, which result in restoration of cardiovascular prophylaxis, were seriously underused in our study population.


Asunto(s)
Aspirina/efectos adversos , Enfermedad de la Arteria Coronaria/inmunología , Hipersensibilidad a las Drogas/inmunología , Anciano , Anciano de 80 o más Años , Aspirina/inmunología , Aspirina/uso terapéutico , California/epidemiología , Enfermedades Cardiovasculares/tratamiento farmacológico , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/prevención & control , Clopidogrel , Enfermedad de la Arteria Coronaria/epidemiología , Hipersensibilidad a las Drogas/epidemiología , Femenino , Humanos , Masculino , Estudios Retrospectivos , Ticlopidina/análogos & derivados , Ticlopidina/uso terapéutico
3.
Am J Rhinol Allergy ; 26(3): 187-90, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22643942

RESUMEN

BACKGROUND: The united allergic airway is a theory that connects allergic rhinitis (AR), chronic rhinosinusitis, and asthma, in which seemingly disparate diseases, instead of being thought of separately, are instead viewed as arising from a common atopic entity. OBJECTIVE: This article describes patients with such diseases; explores ideas suggesting a unified pathogenesis; elucidates the various treatment modalities available, emphasizing nasal corticosteroids and antihistamines; and provides an update of the literature. METHODS: A literature review was conducted. CONCLUSION: The aggregation of research suggests that AR, asthma, and chronic rhinosinusitis are linked by the united allergic airway, a notion that encompasses commonalities in pathophysiology, epidemiology, and treatment.


Asunto(s)
Asma/inmunología , Sistema Respiratorio/inmunología , Rinitis Alérgica Perenne/inmunología , Rinitis Alérgica Estacional/inmunología , Sinusitis/inmunología , Corticoesteroides/uso terapéutico , Asma/tratamiento farmacológico , Enfermedad Crónica , Antagonistas de los Receptores Histamínicos/uso terapéutico , Humanos , Modelos Inmunológicos , Sistema Respiratorio/patología , Rinitis Alérgica Perenne/tratamiento farmacológico , Rinitis Alérgica Estacional/tratamiento farmacológico , Sinusitis/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA